World Health Organization (WHO) International Classification of Functioning, Disability and Health (ICF) Core Set Development for Interstitial Lung Disease

By sjmartinez • November 1, 2022

Saketkoo LA, Escorpizo R, Varga J, Keen KJ, Fligelstone K, Birring SS, Alexanderson H, Pettersson H, Chaudhry HA, Poole JL, Regardt M, LeSage D, Sarver C, Lanario J, Renzoni E, Scholand MB, Lammi MR, Kowal-Bielecka O, Distler O, Frech T, Shapiro L, Varju C, Volkmann ER, Bernstein EJ, Drent M, Obi ON, Patterson KC, Russell AM; Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS). World Health Organization (WHO) International Classification of Functioning, Disability and Health (ICF) Core Set Development for Interstitial Lung Disease. Front Pharmacol. 2022 Oct 14;13:979788. doi: 10.3389/fphar.2022.979788. PMID: 36313333; PMCID: PMC9615472.

Tags: connective tissue, cough, CTD-ILD;, fibrosis, ICD-11, patient-reported outcomes, Publications, Rheumatology

The Ethics of Gene Therapy for Sickle Cell Disease

Patel A, Kuo A. The Ethics of Gene Therapy for Sickle Cell Disease. Cureus. 2025 Mar 23;17(3):e81037. doi: 10.7759/cureus.81037. PMID: 40264617; PMCID: PMC12013961.

Surviving the Odds: Primary Cardiac Lymphoma With Locoregional Lymph Node Involvement Complicated by Pericardial Effusion and Arrhythmia

Bachour K, Shah S, Reichl A, Chia J, Shabsovich DS, Castillo A, Cho G. Surviving the Odds: Primary Cardiac Lymphoma With Locoregional Lymph Node Involvement[...]

Opportunities to Optimize Outcomes of Diagnosis and Treatment of HIV and Syphilis in Pregnancy: the Quest to Eliminate Maternal and Vertical Transmission

Joseph Davey D, de Voux A, Shaetonhodi N, Marks M, Frigati L, Kufa T. Opportunities to Optimize Outcomes of Diagnosis and Treatment of HIV and[...]